Skip to content

Drug interactions

Imatinib + Nilotinib

Severity: Moderate

Imatinib and Nilotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs inhibit CYP3A4 and P-glycoprotein and are substrates of these pathways, so exposure to each may increase. Nilotinib also prolongs the QT interval and combined use increases toxicity concerns.

What this interaction means in plain words

Imatinib and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Mutual inhibition of CYP3A4 and P-glycoprotein reduces clearance of both drugs.

What to do

Avoid routine combination outside specialist protocols. If used, monitor ECG, electrolytes, blood counts and liver tests.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Nilotinib?

MediHelp rates the interaction as moderate. Imatinib and Nilotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs inhibit CYP3A4 and P-glycoprotein and are substrates of these pathways, so exposure to each may increase. Nilotinib also prolongs the QT interval and combined use increases toxicity concerns.

How serious is the interaction between Imatinib and Nilotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine combination outside specialist protocols. If used, monitor ECG, electrolytes, blood counts and liver tests.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in